Cannabidiol (CBD), a Cannabis sativa constituent, is a pharmacologically broad-spectrum
drug that in recent years has drawn increasing interest as a treatment for a range of …

There has been growing clinical, public, and media awareness and concern about the
availability and potential harmfulness of so-called 'legal highs', which are more appropriately …

Acute administration of the primary psychoactive constituent of cannabis, Δ-9-
tetrahydrocannabinol (THC), impairs human facial affect recognition, implicating the …

A convergence of evidence shows that use of Cannabis sativa is associated with increased
risk of developing psychotic disorders, including schizophrenia, and earlier age at which …

Some drugs of abuse may produce dissociative symptoms, but this aspect has been
understudied. We explored the dissociative potential of three recreational drugs (3, 4 …

Abstract The European Food Safety Authority (EFSA) was asked to deliver a scientific
opinion on the risks for human health related to the presence of tetrahydrocannabinol (THC) …

Background Synthetic cannabinoids have emerged as a significant public health concern.
To increase the knowledge of how these molecules interact on brain reward processes, we …

Das Buch vermittelt den aktuellen Stand zum therapeutischen Potential von Cannabidiol
(CBD) sowie seiner Verwendung in Theorie und Praxis. Dr. Franjo Grotenhermen beschreibt …

Points essentiels L'usage de cannabis est devenu plus fréquent que les consommations
d'alcool et de tabac chez les jeunes (15–34 ans), alors qu'il peut entraîner de nombreuses …

Cannabinoid signaling is believed to decrease anxiety, albeit the conflicting nature of
evidence is generally acknowledged. Here we provide a comprehensive overview of …